Oklahoma State University Center for Health Sciences
Oklahoma State University Center for Health Sciences

OSU-CHS News > 2015

Feb. 19, 2015

First Friday Seminar to focus on early treatment of Type 2 diabetes


Matthew L. Bird, Pharm.D., medical science liaison for diabetes at AstraZeneca in Oklahoma City, will discuss early treatment of Type 2 diabetes at noon on Friday, March 6.

The seminar, “Rationale for Early Intensive Treatment of Type 2 Diabetes Mellitus with Combination Therapy,” will examine the advantage of early intensive treatment with a combination of pharmaceuticals for patients with Type 2 diabetes.

Bird earned his bachelor’s degree in biology and his Doctor of Pharmacy at Southwestern Oklahoma State University in Weatherford. He was an assistant professor at the University of Oklahoma College of Pharmacy prior to joining AstraZeneca.

The seminar will be in D-107 and is free and open to the public. It is presented by the OSU-CHS Department of Pharmacology and Physiology.


Return To News Index

 Subscribe in a reader

News Contacts

Dr. Mary Bea Drummond
Assistant Vice President, Marketing and Communications Services

Sean Kennedy
Communications Manager

OSU-CHS on Facebook OSU-CHS on Twitter OSU-CHS on Foursquare OSU Medicine on YouTube Google+